NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









23Mofang

23Mofang

Private
ChengduHealthcare & Life Scienceshttps://www.23mofang.com/

Last Round

VC Round

Aug 26, 2020

Est. Valuation

$37.2M

Total Funding Raised

$37.45M

Company Overview

23Mofang is a biotechnology company that provides direct-to-consumer genetic testing services, offering insights into ancestry, hereditary disease risks, and genetic traits.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, D2C Brands, Precision Medicine

Business Model

B2C

Customer Profile

Hardware Sales, Usage-Based SaaS

AI Layer

Application

Keywords

genetic testingDNA testancestry reportdirect-to-consumer genetic testingDTChealth risk assessmenttrait analysisDNA kitprecision medicinebioinformaticspersonal genomicsgenetic predispositionwellness testingconsumer biotechnologyspit kit

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

23Mofang Comparables

Compare 23Mofang with similar companies based on industry and business-model similarity.

23Mofang comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
WeGene
93%
Genebox
89%
GeseDNA Technology
85%

23Mofang Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundAug 26, 2020
Series B ExtensionMay 31, 2018
Series B ExtensionMar 6, 2018
Series BAug 2, 2017
Series AJan 3, 2017
Pre Seed
Jan 12, 2016

23Mofang Investors

Notable investors and investment history

23Mofang investors
InvestorRounds
Fenghou CapitalAngel, Series B, Pre Seed
Bencao CapitalSeries B Extension
奇点资本Pre Seed
MPCSeries B Extension
Banyan Pacific CapitalSeries B Extension
SB China CapitalSeries B Extension
CD CapitalSeries B Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 6, 2018

    $16M round led by MPC

  • Jan 3, 2017

    Raised $2.87M in Series A funding.

23Mofang Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

23Mofang Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about 23Mofang's valuation, stock price, and market status.

Firmographic Details

HeadquartersChengdu
Employee Range1
Year Founded2015
Last FundingAug 26, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.